Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Recurrent Disease

Tundra lists 3 Recurrent Disease clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05432518

Pilot Trial for Treatment of Recurrent Glioblastoma

This will be a single-arm open-label prospective pilot feasibility trial recruiting 10 adult patients with recurrent glioblastoma who are assigned to receive the personalized study treatment based on the genetic profile of their recurrent GBM tumor resected at the time of surgery. It will be aimed to gather preliminary information on the study intervention and the feasibility of conducting a full-scale trial.

Gender: All

Ages: 18 Years - Any

Updated: 2025-04-25

1 state

Glioblastoma
Recurrent Disease
Recurrent Glioblastoma
ACTIVE NOT RECRUITING

NCT06014619

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Mohs micro-graphic surgery (Mohs) is a tissue-sparing, surgical treatment for different types of skin cancer (e.g. basal cell carcinoma, squamous cell carcinoma, lentigo maligna (melanoma). It is a procedure performed with frozen sections. Slow Mohs, a variant of micro-graphic surgery, is performed by formalin fixation and paraffin-embedded sections. Both in Mohs and Slow Mohs tumor margins are assessed to achieve complete removal. This study aims to investigate the clinical presentation and outcomes (i.e. complications and recurrence rates) in patients treated with Mohs or Slow Mohs in the dermatology department of the Maastricht University Medical Center+ in Maastricht, the Netherlands.

Gender: All

Ages: 16 Years - Any

Updated: 2025-04-04

Skin Cancer
Complication
Complication of Surgical Procedure
+7
RECRUITING

NCT05260671

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

This trial is a multicenter, prospective, single-arm exploratory clinical study to evaluate the efficacy and safety of Penpulimab injection combined with cetuximab in the first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2023-10-18

1 state

Head and Neck Neoplasms
Recurrent Disease
Metastatic Cancer